<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0009">
 <label>9</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Pillaiyar</surname>
    <given-names>T</given-names>
   </string-name>, 
   <string-name>
    <surname>Manickam</surname>
    <given-names>M</given-names>
   </string-name>, 
   <string-name>
    <surname>Namasivayam</surname>
    <given-names>V</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>An overview of severe acute respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: peptidomimetics and small molecule chemotherapy</article-title>. 
  <source>J Med Chem</source>
  <year>2016</year>;
  <volume>59</volume>:
  <fpage>6595</fpage>–
  <lpage>628</lpage>.
  <pub-id pub-id-type="pmid">26878082</pub-id>
 </mixed-citation>
</ref>
